Skip to main content

2020 News

2020 News | 2019 Archives | 2018 Archives | 2017 Archive | 2016 Archive | 2015 Archive


Monday, October 12, 2020

WJLA (Washington, DC): How long can you spread coronavirus once infected? We found out.

Social distancing, hand hygiene and face masks can help curb the spread of the highly contagious coronavirus but if you do get sick, how long can you spread COVID to others? 7 On Your Side went looking for answers.


Friday, October 09, 2020

The Scientist: Scientists’ Advice for Ways to Ward off the Coronavirus

Nine months since the disease now known as COVID-19 first crept into the headlines, standard advice for avoiding it—such as wearing a mask, avoiding crowds, and washing hands well and often—has become familiar. But as winter approaches in the northern hemisphere, and with it an anticipated surge in cases, we sought out additional science-backed tactics to lower the chances of becoming infected, or of developing severe disease.


Thursday, October 08, 2020

NPR: Could The Live Flu Vaccine Help You Fight Off COVID-19?

In case you were still procrastinating getting a flu shot this year, here's another reason to make it a priority. There's a chance the vaccine could offer some protection against COVID-19 itself, says virologist Robert Gallo, who directs the Institute of Human Virology at the University of Maryland School of Medicine and is chairman of the Global Virus Network.


Wednesday, September 30, 2020

GVN’s Top Virus Experts Meet Together To Identify Most Promising Advances To Battle COVID-19 & Strategies To Prepare For Future Pandemics

Rapid Diagnostic Testing, Repurposing Drug Therapies and Vaccines Targeting Innate Immunity, Are Integral Factors in Mitigating COVID-19. The Global Virus Network (GVN), a coalition of the world’s leading medical and basic virology research centers working to prevent illness and death from viral disease, convened a press conference with attendees from across the globe to discuss key takeaways from the GVN virtual 2020 Special Annual Meeting held September 23-24, 2020.


Tuesday, September 29, 2020

NPR: Scientists Experiment With TB Vaccine To See If It Slows Spread Of COVID-19

As scientists race to develop a vaccine specific for COVID-19, some researchers are testing an old vaccine, that's been proven safe and is cheap to manufacture, to see if it could slow the pandemic.


Monday, September 28, 2020

Associated Press: 500 years ago, another epidemic swept Mexico: smallpox

There were mass cremations of bodies; entire families died and the inhabitants of the city, afraid to pull their bodies out, simply collapsed their homes on top of them to bury them on the spot. The scene, beyond even the current coronavirus pandemic, was a scourge brought 500 years ago by Spanish conquistadores and their servants that exploded in Mexico City in September 1520. Smallpox and other newly introduced diseases went on to kill tens of millions of Indigenous people in the Americas who had no resistance to the European illnesses. The viruses later spread to South America, and helped lead to the downfall and overthrow of empires like the Aztecs and Incas. And its lessons remain largely forgotten today.


Thursday, September 24, 2020

Baltimore Sun: A vaccine will help, not end coronavirus pandemic, experts in Maryland and globally say

A global group of virus experts warned Thursday about relying too much on the first vaccines to end the coronavirus pandemic. “If we get a perfect vaccine, great, but that’s unlikely,” said Dr. Robert Gallo, co-founder of the Global Virus Network, during a news conference following a meeting of the organization that works to understand and treat infectious diseases.


Monday, August 31, 2020

UM School of Medicine’s Institute of Human Virology Recruits Top HIV/AIDS Epidemiologist Shenghan Lai Along with Team of Researchers

Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-founder and Director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), and Man E. Charurat, PhD, MHS, Professor of Medicine, Director of the Division of Epidemiology & Prevention and CIHEB Global Director at the IHV, announced today that Shenghan Lai, MD, MPH and Hong Lai, PhD, MPH, in addition to three staff members, and two more to add, have joined the Institute of Human Virology. The faculty began their positions on April 1 with Professor and Associate Professor academic appointments in the UMSOM’s Department of Epidemiology & Public Health.


Friday, August 28, 2020

WYPR: Could Polio Vaccine Corral Covid-19?

A safe, effective vaccine against Covid-19 could resurrect jobs, send kids back to classrooms--change our lives. But how safe and effective? And how quickly can we have it? Dr. Robert Gallo, the AIDS-research pioneer now leading virus science at the Institute of Human Virology at the University of Maryland School of Medicine and the Global Virus Network, argues we could get much of the benefit by inoculating people with an old, very cheap drug -- the oral Polio vaccine developed seven decades ago. Gallo contends it would trigger our ‘innate immunity’-- the body’s emergency response when a threat shows up.


Friday, August 21, 2020

Institute of Human Virology and Italian Researchers identify a SARS-CoV-2 Viral Strain with Deletion in a Protein, Possibly Reducing Fatalities

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome, Italy announced today the results of studies showing the emergence of a SARS-CoV-2 viral strain with a deletion in a protein known as nsp1. These data, accepted for publication today by the Journal of Translational Medicine, (link here) may indicate the emergence of a less pathogenic viral strain.


Tuesday, August 18, 2020

A Statement from the Leadership of the Institute of Human Virology on the Passing of Accomplished Attorney and Social Justice Activist Harry Huge

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, deeply mourns the passing of Board of Advisors member, Harry Huge. Mr. Huge was a founding Board member who was generous in his support of the IHV and the Global Virus Network (GVN), both co-founded by Dr. Robert Gallo.


Monday, August 03, 2020

Eureka, Charles River Laboratories: Could the Oral Polio Vaccine be Used to Prevent COVID-19?

Virologist Robert Gallo, MD, has had a long and storied career in academic and government research. He is the Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology (IHV) at the University of Maryland School of Medicine and co-founder and international scientific adviser of the Global Virus Network. Despite his deep roots in HIV, Dr. Gallo’s current focus is, not surprisingly, COVID-19, which emerged in China last year and within four months morphed into a full-blown pandemic. As usual, Dr. Gallo’s research strategy has raised eyebrows. Unlike the antibody and RNA vaccines that are all the rage in COVID-19 science, Gallo is putting his energies behind repurposing the oral polio virus vaccine developed in the 1950s by Albert Sabin.


Monday, August 03, 2020

Infectious Disease Special Edition: COVID-19 and HIV: Was It a Deadly Mix?

Social distancing is one of the curses of COVID-19, and may fall more heavily on people with HIV than on those without this burden. “People with HIV, and in particular certain subsets of that group—the LGBTQ community, older adults aging with HIV, etc.—face more mental health issues than the general population,” said Sarah Schmalzle, MD, an assistant professor of medicine at the Institute of Human Virology, University of Maryland School of Medicine, in Baltimore. “Many of our patients also already face significant isolation and loneliness due to a combination of HIV stigma, losses of friends and family to HIV, and aging.”


Friday, July 31, 2020

RollingStone-Useful Idiots: Dr. Robert Gallo on a COVID-19 Vaccine

Dr. Robert Gallo, director of the Institute for Human Virology at the University of Maryland School of Medicine, joins the show to give his take on the prospects for an effective COVID-19 vaccine. Gallo is skeptical of the approach many organizations are taking with antibody vaccines, citing the similarly low efficacy those treatments had with HIV due to the low durability of the antibodies. Dr. Gallo’s research is mainly related to Oral Polio Vaccine, which he thinks needs to be tested more in regard to innate immunity.


Friday, July 24, 2020

A Statement from the Leadership of the Institute of Human Virology and the Global Virus Network on the Passing of Renowned Chinese Virologist Yi Zeng

The IHV at the University of Maryland School of Medicine and the Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 55 Centers of Excellence and 10 Affiliates in 32 countries, collectively mourns the passing of Professor Yi Zeng, MD, Academician of the Chinese Academy of Sciences, former President of the Chinese Academy of the Preventive Medicine and former Dean of the College of Life Science and Bioengineering at Beijing University of Technology.


Monday, July 20, 2020

NPR: Early Oxford-AstraZeneca Coronavirus Vaccine Data 'Encouraging,' Scientists Say

Dr. Robert Gallo is quoted about an experimental vaccine candidate being developed by AstraZeneca and Oxford University to protect against COVID-19 that triggered an immune response against the coronavirus and appeared to be safe.


Tuesday, July 07, 2020

Courthouse News Service: Global Progress on Ending HIV/AIDS Derailed by Covid-19

A United Nations program aimed at eliminating HIV/AIDS released a report Monday showing that the global response to the epidemic has fallen far short of goals set for 2020, in large part due to the coronavirus pandemic.


Monday, July 06, 2020

Sputnik Radio: What If There Is No Vaccine for COVID-19?

On today's episode of Loud & Clear, Brian Becker and John Kiriakou are joined by Robert Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific adviser of the Global Virus Network. What would you think if someone told you that we already have a vaccine that at least helps fight Covid-19? That may already be the case. Two American scientists, Dr. Robert Gallo and Dr. Konstantin Chumakov, are positing that decades-old live vaccines for things like polio and tuberculosis strengthen the immune system’s first line of defense a more general way to fight infection. And the history books show us that that sometimes translates into at least some cross-protection against completely different viruses.


Friday, July 03, 2020

KUSI San Diego News: Dr. Robert Gallo suggests an oral polio vaccine could help fight coronavirus

Dr. Robert Gallo from the Institute of Human Virology at the University of Maryland School of Medicine and Global Virus Network wrote an op-ed in the Wall Street Journal earlier this week. The opinion piece stated that OPV, oral polio vaccine, could be a cheap and effective way to fight coronavirus. Dr. Gallo discussed his opinion piece on Good Morning San Diego.


Thursday, July 02, 2020

13D Global Strategy & Research Report

COVID-19 outbreaks are multiplying and immunity may be short-lived. Could existing “live” vaccines, which stimulate innate immunity, outshine vaccines targeting the “spike” protein?


Tuesday, June 30, 2020

Wall Street Journal Op-Ed: An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.

In this op-ed coauthored by Dr. Robert C. Gallo and Daniel J. Arbess, they discuss how “An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.”


Tuesday, June 30, 2020

BBC World Service: Interview with Dr. Robert Gallo

An interview between BBC’s Tim Franks interview with IHV's Dr. Robert Gallo


Monday, June 29, 2020

Baltimore Magazine Special Edition: Dr. Gallo Featured

Dr. Robert Gallo is featured in Baltimore Magazine's special edition, "On the Front Lines: Acts of Courage and Kindness in the Age of Coronavirus."


Friday, June 26, 2020

IHV in the News

Links to news stories featuring the IHV from June 11 to June 25, 2020.


Thursday, June 25, 2020

The New York Times: Dr. Robert Gallo: The Case for a Stopgap Vaccine

In a letter to the editor to The New York Times entitled, "Dr. Robert Gallo: The Case for a Stopgap Vaccine," the noted virologist and head of the IHV says a polio vaccine may be an ideal solution until we find a Covid-specific vaccine.


Wednesday, June 24, 2020

The New York Times: Decades-Old Soviet Studies Hint at Coronavirus Strategy

The New York Times: Decades-Old Soviet Studies Hint at Coronavirus Strategy: A married pair of virologists in Moscow tested a vaccine on their own children in the 1950s. Now, a side effect they found is sparking new hope for a defense against the coronavirus.


Tuesday, June 23, 2020

France 24: Dr. Mohammad Sajadi Speaks with France 24 on COVID-19 and Seasonality

Does Covid-19 spread faster in winter? Modelling by US researchers suggests the transmission of Covid-19 could be seasonal. Mohammad Sajadi, associate professor at University of Maryland School of Medicine's Institute of Human Virology, says the virus first spread in areas of low temperature and low humidity, common to winter time in temperate areas.


Friday, June 12, 2020

Institute of Human Virology and Italian Researchers Find Higher Daily Temperatures Lead to a Decrease in COVID-19 Related Deaths

Insights into population density and daily temperatures provide a path to public health strategies. The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome and Ulisse Biomed and University of Trieste, in Trieste, Italy announced today the results of studies showing an inverse correlation between average high daily temperatures and COVID-19 related death rates in different geographical areas.


Friday, June 12, 2020

The Washington Post: We shouldn’t care who wins the vaccine ‘race’

Dr. Robert Gallo writes a Letter to the Editor to The Washington Post entitled, “We shouldn’t care who wins the vaccine ‘race’,” regarding their June 4 front-page article “Cold War echoes in race for vaccine,” about the “race” among nations, notably the United States, China, and Russia and other European nations for development of a vaccine against the novel coronavirus.


Friday, June 12, 2020

CNN Health: An Existing Polio Vaccine Could Help Protect Against Coronavirus, Top Experts Say

CNN: There is plenty of evidence that existing inoculations such as polio vaccines protect children against a wide range of infections and it's worth trying them out against the new coronavirus, a team of experts wrote in Science magazine Thursday.


Thursday, June 11, 2020

NBC News: Polio Vaccine Could Give Temporary Protection Against COVID-19, Scientists Hope

NBC News: As the world waits for a coronavirus vaccine, some scientists are proposing that existing vaccines could give the body’s immune system a much-needed temporary boost to stave off infection. It’s still unclear whether such an approach would work, and some experts are skeptical. Others — including researchers in Israel, the Netherlands and Australia — are already investigating whether a tuberculosis vaccine could help jump-start the immune system and make COVID-19 less deadly, though the World Health Organization strongly advises against using that vaccine until it’s proven effective against the coronavirus.


Thursday, June 11, 2020

The Washington Post: Can Old Vaccines from Science’s Medicine Cabinet Ward Off Coronavirus?

The Washington Post: Researchers think tuberculosis and polio vaccines could rev up the body’s innate immune system against a new pathogen.


Thursday, June 11, 2020

Global Virus Network Suggests Oral Polio Vaccine May Provide Temporary Protection Against COVID-19

The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence, including the Institute of Human Virology at the University of Maryland School of Medicine, and 10 Affiliates in 32 countries, published a viewpoint in Science today that the stimulation of innate immunity by live attenuated vaccines in general, and oral poliovirus vaccine (OPV) in particular, could provide temporary protection against coronavirus disease 2019 (COVID-19).


Tuesday, June 02, 2020

UM School of Medicine’s Institute of Human Virology Awarded Grants to Strengthen COVID-19 Response in Sub-Saharan Africa

The Center for International Health, Education and Biosecurity (Ciheb) at the University of Maryland School of Medicine’s Institute of Human Virology was awarded $4 million from the U.S. Centers for Disease Control and Prevention (CDC) to support coronavirus disease 2019 (COVID-19) response activities in Botswana, Nigeria, Malawi, and Mozambique.


Monday, May 11, 2020

BBC Global News Interviews Dr. Robert Gallo on Oral Polio Vaccine for SARS-CoV-2 and More

Dr. Robert Gallo appeared on BBC World News with Matthew Amroliwala for a one-on-one, lengthy interview during their Coronavirus Explained segment.


Saturday, May 09, 2020

Dr. Robert Gallo Discuss COVID-19 Research on Aljazeera News

Aljazeera discusses the status of therapy, testing and vaccine research on SARS-CoV-2/COVID-19 with Dr. Robert Gallo.


Thursday, May 07, 2020

The Disappointing Truth About Antibody Testing: There’s still a lot we don’t know about COVID-19

Dr. Robert Gallo discusses the status of COVID-19 antibody test with Vox's The Verge


Wednesday, May 06, 2020

The Coronavirus Appears to have Mutated. What Does that Mean for Contagiousness?

While small mutations in the virus's genetic code are evident, it's unclear what these changes mean for people, if anything at all.


Saturday, May 02, 2020

IHV's Dr. Robert Gallo on FOX's Full Court Press with Greta Van Susteren

Overtime: Dr. Robert Gallo talks coronavirus treatments and antibody testing.


Saturday, May 02, 2020

Dr. Robert Gallo on iHeart Radio to Discuss COVID-19

Ryan Gorman hosts an iHeartRadio nationwide special featuring experts on COVID-19-related issues, including the co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine, the senior vice president for U.S. Programs & Advocacy at Save the Children, and the managing editor of the Military Times. Topics range from a discussion about why some people infected by the coronavirus are asymptomatic, while others face severe reactions and even death, to assistance for impoverished children, and a breakdown of the impact the virus is having on the U.S. military and veterans.


Friday, May 01, 2020

Could an Oral Polio Vaccine Stop the Coronavirus Pandemic?

A YouTube video by the American Chemical Society and produced by PBS.


Friday, May 01, 2020

NYT Op-Ed Features Gallo-Chumakov Oral Polio Vaccine for COVID-19 Idea

What if We Already Have a Coronavirus Vaccine? Researchers are testing whether decades-old vaccines for polio and tuberculosis could protect against infection.


Wednesday, April 29, 2020

Dr. Robert Gallo Appears on C-SPAN’s Washington Journal

Please check out Dr. Robert Gallo’s C-SPAN Washington Journal appearance today to discuss COVID-19 treatments, vaccines, the need for the Global Virus Network, and more.


Monday, April 27, 2020

Expert Breaks Down Coronavirus Research: Is it Worse than HIV? Is it Mutating?

IHV Co-Founder and Director, Robert Gallo, MD is interviewed on LBC, a radio station in the United Kingdom. Darren Adam had Professor Gallo on the line to discuss his research in the past and the work he's carrying out during the coronavirus crisis. "We have learned to live with HIV" Darren began, listing out how it has changed from a death sentence to a disease that humans can live a long life with. He wondered if this could be possibly the path we're taking with Covid-19.


Wednesday, April 22, 2020

Dr. Robert Gallo Featured on National Geographic’s “Jane Goodall: The Hope” on 50th Anniversary of Earth Day

For the 50th anniversary of Earth Day on April 22, 2020, the National Geographic channel will broadcast back-to-back premieres of Photo Ark: Rarest Creatures and Jane Goodall: The Hope.


Wednesday, April 22, 2020

Dr. Robert Gallo on India Today Discussing the Oral Polio Vaccine for COVID-19

IndiaToday on Twitter - “Can oral polio vaccine help in fighting #Covid19? @DrRobertCGallo responds. #NewsToday with @sardesairajdeep


Tuesday, April 21, 2020

USA Today Opinion: An Old Vaccine Could be a New Godsend for Coronavirus

Ultimate control over COVID-19 will be possible only after a large part of the world population becomes immune. This can happen either after a large fraction of the world population gets infected or by prophylactic vaccination. Efforts are underway to accelerate the development of safe and effective vaccines. However, vaccines can be used for mass immunization only if they prove to be safe and effective by thorough clinical evaluation. Given the time this requires, vaccines specific to COVID-19 are likely to remain unavailable for mass immunization during the current pandemic.


Friday, April 17, 2020

Dr. Robert Gallo Discusses Repurposing the Oral Polio Vaccine on CNN

Dr. Robert Gallo discusses repurposing the oral polio vaccine, drug therapies and more on COVID-19 on CNN’s The Lead with Jake Tapper, April 17, 2020.


Monday, April 13, 2020

Can an Oral Polio Vaccine Stop COVID-19?

Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus Network (GVN).


Saturday, April 11, 2020

Institute of Human Virology Honors Legacy of Maeve Kennedy McKean With Global Public Health Fellowship

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today the Maeve Kennedy McKean Global Public Health Fellowship, named in honor of the public health activist, whose inspiring life ended tragically alongside her oldest son last week. The first fellow will arrive on July 1 and will work on the Institute’s efforts in ending the HIV epidemic in Africa within its Center for International Health, Education, and Biosecurity (CIHEB) and Division of Clinical Care and Research.


Thursday, April 09, 2020

IHV and Italian Scientists Identify Unique Mutations in SARS-CoV-2 Found in Europe and North America

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine and scientists from Trieste, Italy announced today the characterization of a novel mutation in the RNA polymerase of certain viral strains of SARS-Cov-2 carried by patients located in Europe and North America. In addition, different patterns of mutations were identified in viral strains corresponding to different geographical areas.


Wednesday, April 08, 2020

Institute of Human Virology Co-founder on Coronavirus Recovery, Antibody Testing, Drug Testing, Bloomberg TV

Dr. Robert Gallo, the Institute of Human Virology at the University of Maryland School of Medicine, Co-founder and director discusses the coronavirus. He speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Asia." (Source: Bloomberg)


Tuesday, April 07, 2020

A Deep Look Into The Coronavirus with Dr. Robert Gallo on WYPR (Baltimore’s local NPR station)

(WNPR) Dr. Robert Gallo has been getting to know viruses-- their targets and their weaknesses--for decades, even before he co-discovered the virus that causes AIDS in the 1980s. At the University of Maryland’s Institute for Human Virology, which he heads, Gallo is looking at the coronavirus; he joins us to share his thoughts. Gallo is also co-founder and international scientific advisor at the Global Virus Network.


Wednesday, April 01, 2020

Dr. Robert Gallo Featured on MSNBC’s 11th Hour with Brian Williams

Robert Gallo, MD, Co-Founder and Director of the Institute of Human Virology, discusses SARS-CoV-2/COVID-19, specifically, how he thinks the fight against the Coronavirus is going thus far.


Friday, March 27, 2020

Covid-19 Is Probably Seasonal, But That’s No Reason to Relax (The Washington Post)

Mohammad Sajadi and Anthony Amoroso are associate professors of medicine at the Institute of Human Virology at the University of Maryland School of Medicine and members of the Global Virus Network. As physicians and researchers, we have spoken to doctors across the country over the past few weeks and kept hearing variations on this description of the novel coronavirus’s spread: It’s like a chemical bomb went off. One day everything seemed normal, and the next everyone became sick: patients, nurses, family members.


Tuesday, March 24, 2020

Maryland Receives Kits for 1,000 Coronavirus Tests from Chinese Company (The Baltimore Sun)

(Source: The Baltimore Sun) A Chinese company has delivered kits for 1,000 coronavirus tests to Maryland through the Institute of Human Virology at the University of Maryland School of Medicine, according to Dr. Robert Gallo, the eminent virologist who leads the institute in downtown Baltimore.


Thursday, March 19, 2020

What COVID-19 Symptoms Look Like, Day By Day

(Source: Business Insider) According to the World Health Organization-China Joint Mission on COVID-19, as of February 20, 80% of laboratory-confirmed cases were mild to moderate, 14% were severe, and 6% were critical. Just to be clear, a mild case of COVID-19 is not like a mild cold. The symptoms will still be pretty severe. Anything less than needing oxygen puts you in this category. Severe cases do need supplemental oxygen, and critical ones are defined by respiratory or multi-organ failure.


Thursday, March 12, 2020

Researchers Predict Potential Spread and Seasonality for COVID-19 Based on Climate Where Virus Appears to Thrive

Researchers at the Institute of Human Virology at the University of Maryland School of Medicine (UMSOM) and the Global Virus Network (GVN) predict that COVID-19 will follow a seasonal pattern similar to other respiratory viruses like seasonal flu. They base this on weather modeling data in countries where the virus has taken hold and spread within the community.


Monday, February 24, 2020

Institute of Human Virology and OncoImmune Launch Clinical Trial to Lessen Effects of HIV Later in Infection

On February 1, the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and OncoImmune, Inc. launched a new Phase II clinical trial called CALIBER, which will test whether OncoImmune’s lead product, CD24Fc, can reduce late effects of HIV infection, such as inflammatory abnormalities including cardiovascular disease. This is intended for use in HIV patients who have been receiving the traditional antiretroviral therapies that control, but do not cure, HIV infection.


Tuesday, February 18, 2020

IHV Clinician Selected as UMSOM 2020 Fellow of the Academy of Education Excellence

Devang M. Patel, MD, Assistant Professor of Medicine, Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), was selected as a UMSOM 2020 Fellow of the Academy of Educational Excellence, established by Carolyn J. Pass, MD ’66 and Richard J. Susel, MD ’66. This honor, which was made possible through the generosity of Dr. Pass and Dr. Susel, is designed to recognize faculty members and other educators who demonstrate excellence in bedside, classroom and/or innovative medical education.


Thursday, February 06, 2020

IHV Joins Global Virus Network (GVN) Discussions with International Top Experts to Combat Growing Novel Coronavirus Epidemic

The GVN, with support from the IHV, Is Bridging Gaps in the Global Emergency Response and Serving as a “Go-To” Resource for Members Needing Assistance in Obtaining and Disseminating Cutting-Edge Scientific Research.